Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
www.marketwatch.com
#Eli #Lillys #weightloss #pill #didnt #work #stock #plunging
Related Posts

Piper Sandler Lifts RPC Target While Keeping Cautious Stance
RPC, Inc. (NYSE:RES) is included among the 13 Best Debt Free Dividend Stocks to Buy Now. Piper Sandler Lifts RPC Target…

Why the Nike stock sell-off hasn’t crossed the finish line yet
The post-earnings slide in Nike’s (NKE) stock isn’t finished yet. Shares of the athleticwear giant plunged 15.5% to close at…

Troubled convenience store chain files for Chapter 11 bankruptcy
ContentsEagles Investments Group files bankruptcyDebtor avoids foreclosure saleEagles Investments Group has 20 locationsChain owner plans to add EV chargersMajor chains…

